Rituximab treatment for persistent scleritis associated with rheumatoid arthritis

Ocular Immunology and Inflammation

Volumn 18, Issue 3, 2010, Pages 223-225

  Iaccheri, Barbara ^a   Androudi, Sofia ^b   Bocci, Elena Bartoloni ^a   Gerli, Roberto ^a   Cagini, Carlo ^a   Fiore, Tito ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Rheumatoid arthritis; Rituximab; Scleritis

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETANERCEPT; METHOTREXATE; MYDRIATIC AGENT; RITUXIMAB;

ADULT; ANTERIOR EYE SEGMENT; ARTICLE; BLURRED VISION; CASE REPORT; CLINICAL FEATURE; CORNEA LIMBUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; DRUG WITHDRAWAL; EYE PAIN; HUMAN; IRIDOCYCLITIS; KERATITIS; MALE; RECURRENT DISEASE; REMISSION; RHEUMATOID ARTHRITIS; SCLERITIS;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; REMISSION INDUCTION; SCLERITIS;

EID: 77952864320     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273941003739928     Document Type: Article

References (10)

1. Shaw T, Quan J, Totoritis MC. B cells therapy for rheumatoid arthritis: the rituximab (anti CD20) experience. Ann Rheum Dis. 2003;62:55-59.
2. Takemura S, Klimiuk PA, Braun A, et al. T cell activation in rheumatoid synovium is B cells dependent. J Immunol. 2001;167:4710-4718.
3. Okhravi N, Odufuwa B, McCluskey P, et al. Scleritis. Surv Ophthalmol. 2005;50:351-363.
4. Freidlin J, Wong IG, Acharya N. Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis. Br J Ophthalmol. 2007;91:1414.
5. Cheung CMG, Savage COS. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab. Br J Ophthalmol. 2005;89:1542.
6. Keystone E, Fleischmann R, Emery P, et al. Safety and efficacy of additional course of rituximab in patients with active rheumatoid arthritis: an open label extension analysis. Arthritis Rheum. 2007;56:3896-3908.
7. Foster CS, Tufail F, Waheed NK, et al. Efficacy of etanercept in preventing relapses of uveitis controlled by methotrexate. Arch Ophthalmol. 2003;121:437-440.
8. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med. 2005;352:351-361.
9. Taban M, Dupps WJ, Mandell D, Perez VL. Etanercept (Enbrel)- associated inflammatory eye disease: case report and review of the literature. Ocul Immunol Inflamm. 2006;14:145-150
10. Kurz PA, Suhler EB, Choi D, Rosenbaum JT. Rituximab for treatment of ocular inflammatory disease: a series of four cases. Br J Ophthalmol. 2009;93:456-458.